What is the recommended treatment plan for a patient with diabetes?

Recommended Treatment Plan for Diabetes

All patients with diabetes must begin comprehensive lifestyle modifications immediately—including diabetes self-management education, medical nutrition therapy, and at least 150 minutes weekly of moderate-intensity aerobic activity plus resistance training twice weekly—alongside pharmacotherapy, as this combined approach reduces A1C by 0.3-2%, lowers mortality risk, and prevents cardiovascular complications regardless of diabetes type. 1, 2

Universal Foundation: Lifestyle Modifications (Required for ALL Patients)

Every patient with diabetes must start with these non-negotiable interventions:

• Diabetes self-management education and support at diagnosis and continuously throughout care, as this reduces mortality risk and healthcare costs with high-quality evidence 1, 2
• Medical nutrition therapy delivered by a registered dietitian, which reduces A1C by 0.3-2% in type 2 diabetes and 1.0-1.9% in type 1 diabetes 1, 2
• Physical activity prescription: 150 minutes per week of moderate-intensity aerobic exercise spread over at least 3 days with no more than 2 consecutive days without activity 1, 2
• Resistance training: 2-3 sessions per week on nonconsecutive days 2, 3
• Weight loss: Minimum 5% body weight reduction for all overweight/obese patients with type 2 diabetes 1, 2

The nutrition plan should focus on reducing saturated fat, trans fat, and cholesterol intake while increasing omega-3 fatty acids, viscous fiber, and plant stanols/sterols 4, 3. Various eating patterns can be effective, including Mediterranean-style, DASH, plant-based, lower-fat, and lower-carbohydrate patterns 3.

Type 2 Diabetes: Stepwise Pharmacologic Algorithm

Step 1: Metformin as First-Line Agent

Metformin must be initiated at or soon after diagnosis alongside lifestyle modifications due to its efficacy, safety, low cost, cardiovascular benefits, and mortality reduction 1, 2, 5. Metformin reduces A1C by approximately 1.4% and fasting plasma glucose by 53 mg/dL 5.

Critical exception: For patients with established atherosclerotic cardiovascular disease, heart failure, or chronic kidney disease at diagnosis, immediately add an SGLT2 inhibitor or GLP-1 receptor agonist with proven cardiovascular benefit alongside metformin 1, 2.

Step 2: Add Second Agent if Targets Not Met in 3 Months

When monotherapy with metformin at maximum tolerated dose does not achieve or maintain blood glucose targets over 3 months, add a second agent based on the following algorithm 3:

• For patients with heart failure: Add SGLT2 inhibitor for glycemic management and prevention of heart failure hospitalizations 2
• For patients with chronic kidney disease: Add SGLT2 inhibitor to minimize CKD progression, reduce cardiovascular events, and reduce heart failure hospitalizations 2
• For patients with advanced CKD: Add GLP-1 receptor agonist (preferred over SGLT2 inhibitor) for glycemic management due to lower hypoglycemia risk and cardiovascular event reduction 2

Metformin Contraindications and Precautions

Metformin is contraindicated in severe renal impairment (eGFR below 30 mL/min/1.73 m²) due to increased risk of lactic acidosis 5. It is not recommended in patients with hepatic impairment 5. Assess renal function before initiating and monitor regularly, especially in elderly patients 5.

Type 1 Diabetes: Insulin-Based Management

Multiple daily insulin injections (≥3 injections daily) or continuous subcutaneous insulin infusion are mandatory from diagnosis for all patients with type 1 diabetes 1, 2, 3.

Key insulin management principles:

• Insulin analogues must be used instead of regular human insulin to significantly reduce hypoglycemia risk 1, 2
• Automated insulin delivery systems should be considered for all adults with type 1 diabetes 2
• Patients must receive education on matching mealtime insulin doses to carbohydrate intake, fat, and protein intake, modifying insulin dose based on concurrent glycemia and glycemic trends, sick-day management, and anticipated physical activity adjustments 2

Initial insulin dosage for type 1 diabetes ranges from 0.25 to 1.0 U per kg per day 6.

Glycemic Targets and Monitoring

Blood Glucose Goals by Clinical Setting:

Critically ill patients:

• Initiate insulin therapy for persistent hyperglycemia starting at threshold ≤180 mg/dL 4
• Target glucose range of 140-180 mg/dL for majority of critically ill patients 4
• More stringent goals of 110-140 mg/dL may be appropriate for selected patients if achievable without significant hypoglycemia 4

Non-critically ill hospitalized patients:

• Premeal blood glucose targets generally <140 mg/dL 4
• Random blood glucose <180 mg/dL are reasonable if safely achieved 4
• Scheduled subcutaneous insulin with basal, nutritional, and correction components is the preferred method 4

Outpatients: Set targets based on patient's age, comorbidities, risk of hypoglycemia, and life expectancy 3. Monitor A1C every 3-6 months 3.

Cardiovascular Risk Factor Management

Blood Pressure Control

• Target blood pressure <140/90 mm Hg for patients with diabetes and hypertension 2, 3
• Patients with systolic BP 130-139 mmHg or diastolic BP 80-89 mmHg may receive lifestyle therapy alone for maximum 3 months, then add pharmacologic agents if targets not achieved 4
• Patients with more severe hypertension (systolic ≥140 or diastolic ≥90 mmHg) should receive pharmacologic therapy in addition to lifestyle therapy 4
• Initiate ACE inhibitor or ARB (but not both) as first-line antihypertensive for renal protection 2, 3

Lipid Management

• Initiate at least moderate-intensity statin therapy for most patients aged 40 years or older to reduce cardiovascular mortality 2, 3
• For patients with overt cardiovascular disease, target LDL cholesterol <70 mg/dL using high-dose statin 4
• For patients without overt cardiovascular disease, target LDL cholesterol <100 mg/dL 4
• If drug-treated patients do not reach targets on maximal tolerated statin therapy, a reduction in LDL cholesterol of 30-40% from baseline is an alternative therapeutic goal 4

Hypoglycemia Management Protocol

Every hospital and practice must have a hypoglycemia management protocol 4:

• Treat hypoglycemia (glucose <70 mg/dL) with 15-20 grams of rapid-acting glucose, preferably pure glucose 2, 3
• Glucagon must be prescribed for all individuals taking insulin or at high risk for hypoglycemia; family and caregivers must know its location and administration 2
• Severe or frequent hypoglycemia is an absolute indication for treatment regimen modification 1, 2
• Patients with hypoglycemia unawareness should increase glycemic targets for several weeks 1

Screening for Complications

Implement the following screening schedule:

• Annual comprehensive dilated eye examination by ophthalmologist or optometrist starting immediately at diagnosis 2
• Annual comprehensive foot examination including visual inspection for skin integrity, callous formation, deformities, or ulcers 2
• Annual laboratory monitoring: lipid profile, spot urinary albumin-to-creatinine ratio, serum creatinine and eGFR, liver function tests, thyroid-stimulating hormone, vitamin B12 levels, and serum potassium 2

For children with type 1 diabetes, screen for thyroid disease using thyroid peroxidase and thyroglobulin antibodies soon after diagnosis 4. Measure TSH concentrations after metabolic control has been established; if normal, recheck every 1-2 years 4.

Immunizations

• Annually provide influenza vaccine to all diabetic patients ≥6 months of age 4
• Administer pneumococcal polysaccharide vaccine to all diabetic patients ≥2 years of age 4
• Administer hepatitis B vaccination to adults with diabetes per CDC recommendations 4

Critical Pitfalls to Avoid

• Never delay adding SGLT2 inhibitor or GLP-1 receptor agonist in patients with established cardiovascular disease, heart failure, or chronic kidney disease 1, 2
• Never continue aggressive glycemic targets in patients experiencing severe or frequent hypoglycemia 1, 2
• Never neglect ongoing lifestyle modifications throughout the entire treatment course regardless of medication regimen 1, 2
• Never aggressively lower blood pressure below 130/70 mm Hg in older adults due to increased mortality risk 2
• Never use sliding scale insulin alone in hospitalized patients; scheduled subcutaneous insulin with basal, nutritional, and correction components is required 4